Skip to main content
Premium Trial:

Request an Annual Quote

Qiagen to Provide Technologies for Blood Screening Program in Brazil

NEW YORK (GenomeWeb News) – Qiagen today said that it will provide molecular sample and assay technologies for a PCR-based blood screening program for HIV and hepatitis C virus in Brazil.

The contract — signed with Bio-Manguinhos, which provides vaccines and diagnostics to the Brazilian Ministry of Health — will run for five years, following approval by Brazilian patent authorities. The deal contains options for subsequent extensions, said Qiagen.

The new, national screening is scheduled to start next year. Qiagen estimated that around 5 million blood donations are performed each year in Brazil.

"The new program marks the effort to complement these traditional, immunodiagnostic tests with nucleic-acid-based, molecular assays that are considered significantly more sensitive in detecting infection," Qiagen said in a statement.

The firm recently has been expanding its presence in the Latin and South American markets. Late last year, Qiagen announced that the Mexican Public Health Agency would launch a human papillomavirus screening program that would include the use of its Digene molecular HPV assay.

Filed under

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.